impact of cigarette smoking in the early bone tissue response, in the peri-implant crestal bone loss and in the prevalence of complications around implants (ALHarthi, 2017; Atieh, Alsabeeha, Faggion, & Duncan, 2013; Krennmair, Weinländer, Forstner, Krennmair, & Stimmelmayr, 2016) . Several studies, including meta-analysis, also indicated that smoking increases the risk of dental implant failure (Chen, Liu, Xu, Qu, & Lu, 2013 , Chrcanovic et al., 2015 , BrignardelloPetersen, 2017 .
Thus, although dental implant placement is an effective and successful therapeutic strategy for replacing missing teeth in fully and partially edentulous patients, the use of this therapy in patients with compromising risky habits, as smoking, has not been predictable (Papathanasiou, Finkelman, Hanley, & Parashis, 2016) . In fact, experimental (Giorgetti et al., 2010) and clinical (Campos et al., 2015) studies have revealed that smoking modulates gene expression of key bone-related molecules, also inducing reactive oxygen species (ROS) production and promoting cellular oxidative stress which may negatively influence osteoimmunology signaling molecules (Agnihotri et al., 2009 ). In addition, smoking harmfully changes the pattern of host response (Ataoglu et al., 2002; Peruzzo et al., 2016) , suppressing the osteo-immuno-inflammatory mediator profile around dental implants even in non-manifesting inflammation sites (Negri et al., 2016) .
Consequently, implant modifications and systemic agents have
been tested in smoking conditions, although none has been described as a potential and/or safe mediator of bone metabolism in this at-risk circumstance (Chrcanovic et al., 2015; Lima et al., 2013) . Lima et al. (2013) 
investigated the effect of Recombinant Human
Parathyroid Hormone (PTH 1-34) on attenuating the influence of cigarette smoking on bone around titanium implants in rats and suggested that this agent increased bone volume around implants.
However, the PTH (1-34) side effects as hypercalcemia and increased incidence of osteosarcoma (Jolette et al., 2006; Vahle et al., 2002) require that a protocol for the use of this substance in implant therapy should be established, if possible including shortterm period and low doses of PTH (1-34). Additionally, even modification on surface properties of dental implants, such as topographic and chemic, known to improve the osseointegration process (Wennerberg & Albrektsson, 2010) , seems not promote benefits in the survival of implants in smokers (Chrcanovic et al., 2015) , and not overcome the detrimental effect of tobacco smoking on bone around implants (Correa et al., 2009 ).
Thus, strategic alternatives that could promote therapeutic benefits in this at-risk circumstance associated with reduced side effects need to be further investigated. In this context, the use of products prepared from plants and its components has increased. Among these compounds, resveratrol (trans-3,4,5'-trihydroxystilbene) (RESV), an active substance in food, such as red grapes, peanuts, and berries, has become therapeutically important considering findings from pharmacological and clinical studies supporting its anticancer effect on various human cancer cells, among other proprieties as anti-inflammatory and antioxidant Corrêa et al., 2017; Lang et al., 2015; Sadi & Konat, 2016) . Additionally, its inhibitory effect on osteoclast differentiation and its potential to induce bone formation have also been evidenced (Tseng et al., 2011 , Casarin et al., 2014 , Ornstrup et al., 2016 .
Regarding with smoking condition, studies showed that RESV intake exerts favorable impact on inflammatory markers and oxidative stress in smokers, reducing the concentrations of C-reactive protein, and increasing the levels of total antioxidants in individuals with this habit, supporting therapeutic impact in these patients (Bo et al., 2013) . In line, it has been mentioned that RESV inhibits the cigarettes' harmful effects on diverse tissues, including bone (Andreou et al., 2004; Arcand et al., 2013; Franck et al., 2018; Kurus, Ugras, Ates, & Otlu, 2009; Ribeiro et al., 2017) . However, to the authors' knowledge from literature, the role of RESV in enhancing new bone formation around dental implants in a scenario of chronic smoking habit has not been investigated yet. Considering the RESV potential for improving bone repair in other experimental models and taking into account the damage promoted by smoking during osseous periimplant repair, it would be important to investigate the benefits of this natural agent during bone repair around implants in the presence of tabagism.
| MATERIAL S AND ME THODS

| Animals
The experimental procedure was approved by the Animal Care and Use Committee of University (Permit Number: 226/14) and according to the ARRIVE guidelines. The animal cohort was composed of 54 10-week-old male Wistar rats, weighing 356 ± 89 g at the beginning of the study. The rats were acclimatized for 15 days before use, and they were kept in temperature-controlled cages, exposed to a 24-hr light-dark cycle of equal time, and had free access to water and food ad libitum (Labina, Purina1, Paulinia, SP, Brazil) in the Bioterium of University.
| Treatment groups
Animals were allocated into three groups: CSI+RESV-daily administration of resveratrol and CSI exposure (n:18); CSI+PLA-daily administration of placebo and CSI exposure (n:18); and non-CSI-daily administration of placebo and no CSI exposure (n:18). The administration of resveratrol (10 mg/Kg) and placebo occurred via gavage for 30 days following surgery, according to Casarin et al. (2014) . A exposed to the smoke of 10 cigarettes (concentration 1.3 mg of nicotine, 16.5 mg of tar, and 15.2 mg of carbon monoxide), as previously described (Correa et al., 2009 ). The animals go through 2 days of adaptation: On the first day, they are exposed for periods of 5 min, while on the second day the exposure is for 7 min.
From then on, in day −7 of the experiment, the animals were exposed to three daily periods of 8 min (Correa et al., 2009) , until the end of the study (day 30). Animals assigned to the group not being exposed to cigarette smoke were handled and inserted into similar acrylic boxes during the same trial period, but without the smoke exposure.
| Implant placement
Two implants were placed in each animal, one in each tibia, at the proximal aspect of the tibial metaphysis. Under anesthesia, an incision of 1.0 cm in length was made, and the bone surfaces of the tibiae were surgically exposed by blunt dissection. Bicortical implant beds were drilled at a rotary speed not exceeding 1,500 rpm. A screw-shaped, commercially available pure titanium implant, 4.0 mm in length and 2.2 mm in diameter (Implacil de Bortoli, São Paulo, SP, Brazil), was placed in each tibiae until the screw threads had been completely embedded in the bone cortex (Casarin et al., 2014; Figure 1a-d) . The soft tissues were replaced and sutured.
| Postoperative period
The animals were evaluated daily throughout the experiment to check for possible clinical or toxicological symptoms. Thirty days after the start of the study, the animals were euthanized by CO 2 inhalation. After the tibiae have been dissected to expose the implants, randomly one of the implants was removed for a torque force evaluation, and subsequently, the peri-implant tissue was stored in RNA later (Ambion Inc., Austin, TX, USA) for gene expression analysis. The other tibiae (including the inserted implant) was removed and stocked in 70% alcohol for evaluation by microCT scans.
| Torque force evaluation for the removal of implants
After exposition of the implant, the attachment of a torque meter (Mark-10, BGI, CA, USA) with a scale range of 0.1-10 N/cm and divisions of 0.05 N/cm was obtained. A wrench was adapted to the implant head to apply torque in the reverse direction of implant placement until complete rupture of the bone-implant interface was signaled by rotation of the implant. The torque force value achieved in N/cm was considered as the torque necessary for the breakdown of osseointegration . 
| Gene expression analysis
The peri-implant sample was stored in RNA later at −70°C for the evaluation of the mRNA levels of BMP-2, OPN, Runx2, Lrp-5, Osx, β-catenin, Dkk1, OPG, and RANKL. Total RNA from the biopsies was isolated by the Trizol method (Gibco BRL; Life Technologies, Rockville, MD, USA) according to the manufacturer's recommendation and previously described by our group in a previous study (Conte et al., 2015) . Initially, RNA samples were resuspended in diethylpyrocarbonate-treated water and stored at −70°C. The RNA concentration was determined from the optical density using a micro-volume spectrophotometer (NanoDrop 1000; NanoDrop Technologies LLC, Wilmington, NC, USA).
Total RNA was DNase treated (Turbo DNA-frees; Ambion Inc.), and 1 μg was used for complementary DNA (cDNA) synthesis.
The reaction was carried out using the First-Strand cDNA synthesis kit (Roche Diagnostic Co., Indianapolis, IN, USA), following the manufacturer's recommendations. Primers were designed using a probe design software (LightCycler Roche probe design software;
Diagnostics GmbH, Mannheim, Germany) ( 
| Microcomputed tomography analysis
Non-demineralized specimens were scanned by a cone-beam microcomputed tomography (microCT) system (Skyscan 1172;
Bruker, Kontich, Belgium). The X-ray generator was operated at 
| Data analysis
Statistical analysis was performed using SAS software (Program Release 9.3; Cary, NC, USA). The data were examined for normality by the Kolmogorov-Smirnov test. Since the torque force and microCT data achieved normality, parametric methods were used for the comparisons. Then, one-way analysis of variance (ANOVA) was used for comparison of the biomechanical retention of titanium implants evaluation and microCT parameters. When there were significant differences by ANOVA, a pair-wise comparison was performed by the Tukey test.
Considering that the gene expression data did not achieved normality, non-parametric methods were used for the comparisons. Thus, the significance of differences in the relative gene expression levels analysis was compared using Kruskal-Wallis test. When there were significant differences by the Kruskal-Wallis test, a pair-wise comparison was performed by the Dunn's test. The significance level established for all analyses was 5%.
| RE SULTS
| Torque force evaluation
Data analysis demonstrated statistical differences between groups for the counter-torque analyses, indicating that resveratrol posi- 
| MicroCT analysis
Data analyses showed that CSI promoted negative effects in all evaluated parameters around the implants, providing reduced BIC 
| Gene expression levels
The gene expression analysis indicated that the levels of RANKL/ OPG (p = 0.0103) and Lrp-5 (p = 0.0268) were negatively modulated in CSI+placebo group when compared to non-CSI. The use of RESV in rats exposed to CSI was efficient to reverse the negative effect of smoking, improving the mRNA levels of RANKL/OPG (p = 0.0342) and Lrp-5 (p = 0.0189) when compared to CSI+placebo. Additionally, higher expression of β-catenin was verified in CSI+RESV when compared to CSI+placebo group (p = 0.0362; Table 2 ).
| D ISCUSS I ON
Some factors could negatively interfere on implant survival and incidence of complications, such as tabagism. Smoking has negatively influenced survival and success rates of dental implants, promoting a higher prevalence and severity of peri-implant lesions, bone loss around dental implants and implant failure (Atieh et al., 2013; Chrcanovic et al., 2015) . Resveratrol is a natural compound with innumerous biological properties including inhibitory effect on osteoclast differentiation and potential to induce bone formation Shakibaei, Buhrmann, & Mobasheri, 2011; Tseng et al., 2011) . Understanding the damages caused by smoking in the periimplant tissues and considering the positive impact of resveratrol in improving bone healing, the present investigation evaluated the possible benefits of this substance in stimulating peri-implant bone healing in smoking rats. The present study revealed that resveratrol improves the bone repair around titanium implants in rats submitted to CSI, exerting a favorable influence on gene expression of bone-related markers in the peri-implant tissues.
Literature has already revealed beneficial effects of resveratrol on the repair of bone tissues in in vitro (Tseng et al., 2011) as well as in vivo models Casarin et al., 2014) . Nevertheless, this is the first study to determine the role of resveratrol on the bone repair around titanium implants in the presence of chronic exposure to cigarette smoke. In this investigation, daily resveratrol intake increased the reverse-torque values for implant removal in rats exposed to cigarette smoke when compared to those exposed to cigarette smoke that did not receive this therapy (p < 0.05). In agreement, microCT analyses of this study showed that both animals exposed to cigarette smoke treated with RESV and non-CSI rats presented augmented BIC when compared to animals submitted to CSI that received placebo (p < 0.05). These promising outcomes support the benefits of the systemic use of resveratrol in improving bone healing around implants, even in at-risk systemic conditions, such as tabagism.
The encouraging biomechanical retention and the peri-implant bone formation results achieved by resveratrol use in the presence of tabagism observed in the present study could be explicated, at least levels of RANKL/OPG were negatively modulated in smoking rats treated with placebo when compared to animals did not exposed to CSI (p < 0.05). According to the data from the current study, the use of resveratrol may reverse the negative impact of smoking around implants, reducing the expression of RANKL/OPG in the peri-implant tissues during bone repair. In accordance with the current data, Franck et al. (2018) evaluating the benefits of resveratrol in the repair of critical-sized calvarial defects in smoking rats, recently demonstrated that the systemic use of this substance significantly reduced the values of mRNA of RANKL/OPG in rats submitted to CSI when compared to smoking rats treated with placebo. In line, remarkable data were shown by an in vitro study (Singh et al., 2000) , supporting that resveratrol may antagonize Aryl hydrocarbon receptor (AhR) ligands, a cigarette smoke compound that promotes osteoclastogenesis. Additionally, Shakibaei et al. (2011) demonstrated that resveratrol can exert anti-osteoclastogenic effects, which is most likely mediated through the suppression of RANKL, in line with our outcomes, even in an at-risk condition as smoking.
F I G U R E 4
Representative three-dimensional rendered images of the bone around implant (blue) and bone-implant contact "BIC" (yellow) at a controlled distance from the implant surface, in groups CSI+RESV (a,d), CSI+placebo (b,e), and non-CSI (c,f) TA B L E 2 Mean ± (SD) of relative levels of mRNA for all genes (mRNA gene/mRNA GAPDH)
Additionally, the present investigation showed that resveratrol therapy was efficient to up-regulate Lrp-5 and β-catenin mRNA levels in smoking animals when compared to those submitted to CSI and treated with placebo solution (p < 0.05). Wnts are a family of secreted proteins existing extensively within the skeleton that can bind to the Lrp5 co-receptor leading to the stabilization of β-catenin in the cytoplasm, and promoting additional Wnt-targeted gene transcription (Krishnan, Bryant, & Macdougald, 2006) . Lrp-5, which is a co-receptor for Wnt proteins, is known to have an important role in skeletal metabolism (Ashouri et al., 2015) . In general, activation of canonical Wnt signaling can increase bone formation via multiple routes, including promoting the differentiation of mesenchymal stem cells into mature osteoblasts, augmenting the proliferation and mineralization of osteoblasts, and preventing the osteoblast apoptosis (Krishnan et al., 2006) . Evidence has also revealed the importance of canonical Wnt signaling in regulating the expression of osteogenesis-related mediators (Zhang et al., 2013) . Accordantly, Franck et al. (2018) revealed that resveratrol therapy decreased Dkk1 levels in repaired bone tissue from calvarial defects when compared to both smoking rats treated with placebo and non-CSI animals, differently from the current findings. Other investigations, using mesenchymal cells (Zhou et al., 2009 ) and experimental models with systemically healthy animals (Casarin et al., 2014) , indicated that resveratrol seems to induce the expression of bonerelated markers as Osx, Runx-2, OCN, BMP-2, BMP-7, and OPN, in contradiction to some results from the present investigation.
Conflicting outcomes among studies may be related to the experi- Collectively, the positive outcomes observed after resveratrol therapy in the present study may be used, in future, to control or overcome the harmful effects of smoking on bone tissues and consequently reduce the clinical problems around implants related to this damaging habit. However, more studies should be conducted to confirm these results, given that this is the first one investigating the role of resveratrol daily use in the bone repair around implants in tabagism conditions, examining in vivo peri-implant bone biopsies.
Additionally, despite the fact that models of implant in the tibia have been widely used to research hypotheses regarding peri-implant bone repair (Casarin et al., 2014; Correa et al., 2009; Ribeiro et al., 2006; Ribeiro, Nociti, Sallum, & Casati, 2009; Pimentel et al., 2016) , they may not faithfully reproduce events in intra-oral bone tissues and further investigations should be considered using oral models of dental implants.
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